# Final review: Arterial local adaptation

## Strengths

- The local app remains dependency-free and loads its scripts and styling from the project folder. Road geometry, save validation, presentation, and the original simulation are sensibly separated.
- New road construction previews use the same resolved endpoints as commit. The build path splits ordinary road crossings and rejects cramped intersections before changing the graph.
- Save validation covers versions, numeric bounds, references, duplicate connections, zones, buildings, camera values, and collection limits. Restore rebuilds the candidate graph before swapping most live state.
- The supplied Node suite is reported as passing 43/43. Focused read-only harness checks confirmed the road and persistence behaviors described below.

## Critical

None found.

## Re-review

The earlier findings are addressed in the follow-up revision. The long duplicate subsegment now leaves the city unchanged, while the five-degree crossing reaches the splitter and creates a four-way junction.

- `buildRoad()` now detects coincident paths before splitting, and the added test confirms a rejected overlap leaves the captured network and active cars unchanged.
- `reshapeRoad()` validates a candidate curve before changing the live edge. Its regression test rejects a crossing bend without changing geometry, while a safe bend succeeds.
- `CitySave.validate()` requires each declared ring to have exactly one incoming and outgoing ring edge per member and verifies that those edges form one cycle covering all members. Tests reject both missing edges and disjoint cycles.
- `Path.nearest()` now refines the coarse arc-length estimate with a numeric solve on the quadratic curve, and the curved-road branch regression asserts that the inserted endpoint is a degree-3 junction. `README.md` is present.

## Important

None found.

## Minor

None found.

## Verdict

The overlap transaction, bend validation, ring-import validation, shallow crossing, and curved-branch connection cases all pass focused re-review checks. The supplied full suite is reported as passing 43/43, and no Critical or Important findings remain. Approved.
